Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLIT3 antisense RNA 2 (SLIT3-AS2) is a long non-coding RNA transcribed from the SLIT3 gene locus in the antisense orientation. While antisense RNAs like SLIT3-AS2 often function as regulators of gene expression, possibly modulating the expression of their sense counterparts through epigenetic or transcriptional interference, SLIT3-AS2 itself does not code for a protein nor is it a typical therapeutic target such as a receptor or enzyme. Its biological and disease roles are inferred from broader research on non-coding RNAs and the SLIT3 locus, which is implicated in processes such as axon guidance, vascular development, and cancer suppression, but direct functional characterization of SLIT3-AS2 remains limited in the current literature[3].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLIT3 antisense RNA 2 (SLIT3-AS2).